Pipette-operable microfluidic devices with hydrophobic valves in sequential dispensing with various liquid samples: multiplex disease assay by RT-LAMP

• Published in: Lab on a chip 2024-06, Vol.24 (12), p.3112-3124
• Main Authors: Chang, Yen-Wei, Lin, Jhih-Pu, Ling, Shiu-Jie, Chen, Yen-Chun, Liu, Helene Minyi, Lu, Yen-Wen
• Format: Article
• Language: English
• Subjects: Chambers; COVID-19 - diagnosis; COVID-19 - virology; Dispensing; Equipment Design; Flow resistance; Humans; Hydrophobic and Hydrophilic Interactions; Hydrophobicity; Influenza; Lab-On-A-Chip Devices; Liquids; Microfluidic Analytical Techniques - instrumentation; Microfluidic devices; Nucleic Acid Amplification Techniques - instrumentation; Pipettes; Point-of-Care Testing; Printing, Three-Dimensional; SARS-CoV-2 - isolation & purification; Three dimensional printing; Valves
• ISSN: 1473-0197; 1473-0189; 1473-0189
• DOI: 10.1039/d4lc00209a

Microfluidic dispensing technologies often require additional equipment, posing challenges for their integration into point-of-care testing (POCT) applications. In response to this challenge, we have developed a pipette-operable microfluidic device fabricated using 3D printing technology for precise liquid dispensing. This device features three reaction chambers and three distinct hydrophobic valves to control the flow direction of liquids. Through these valves, the pipette-operable microfluidic device can sequentially dispense and isolate the liquid into the three reaction chambers, allowing for the individual conduction of three distinct reactions. These hydrophobic valves, with optimized flow resistance and burst pressure, can sustain a volumetric flow rate of up to 25 μL s −1 , making them compatible with a standard pipette, a syringe, or a dropper operation. Furthermore, the device is successfully used to operate with various liquids, including BSA, DMEM, FBS, plasma, and blood, representing that the device has the potential to be used for various applications. Additionally, distinct RT-LAMP primer sets have been incorporated for diagnosing SARS-CoV-2, influenza A, and influenza B within each chamber through lyophilization. This pipette-operable microfluidic device serves as a versatile tool for diagnosing these three diseases using a single loading process, with results readable by the naked eye or image assay within 30 minutes of incubation. Finally, the design concepts are extended to engineer a microfluidic device with 20 reaction chambers, offering significant potential for multi-disease diagnostics. The pipette-operated microfluidic device allows for sequential dispensing and isolation of liquid into individual chambers through manual pipetting.